Journal Mobile Options
Table of Contents
Vol. 88, No. 3, 1997
Issue release date: 1997
Cardiology 1997;88:223–237

Acute Coronary Syndromes

Yun D.D. · Alpert J.S.
aSection of Cardiology, Department of Medicine, University of Arizona, and bDepartment of Medicine, University of Arizona, College of Medicine, Tucson, Ariz., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Acute coronary syndromes are defined as unstable angina, non-Q-wave myocardial infarction, and Q-wave myocardial infarction. These entities remain among the commonest life-threatening illnesses in industrialized nations. Prompt recognition of a patient with an acute coronary syndrome is important since appropriate therapy can markedly improve the patient’s prognosis. Reperfusion strategies for patients with Q-wave myocardial infarction, and anticoagulation and antiplatelet therapy for patients with unstable angina or non-Q-wave myocardial infarction are examples of such potentially life-saving interventions. A number of adjunctive pharmacological interventions are also beneficial following reperfusion therapy in patients with Q-wave myocardial infarction. Management of complications following Q-wave myocardial infarction has improved markedly in recent years. This is particularly the case with postinfarction ischemia or heart failure. Persistent arrhythmias, and in particular ventricular arrhythmias, remain a troubling challenge for the clinician. Reperfusion therapy markedly reduces the incidence of complications following Q-wave myocardial infarction

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50